Eli Lilly Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Feb 24 | SellUS$132,521,930 | Lilly Endowment, Inc, Endowment Arm | Company | 169,684 | US$793.08 | |
15 Feb 24 | SellUS$38,263,417 | Lilly Endowment, Inc, Endowment Arm | Company | 50,316 | US$762.26 | |
09 Feb 24 | SellUS$152,753,428 | Lilly Endowment, Inc, Endowment Arm | Company | 206,257 | US$745.24 | |
08 Feb 24 | SellUS$6,470,336 | Lilly Endowment, Inc, Endowment Arm | Company | 8,743 | US$740.06 | |
31 Jan 24 | SellUS$50,920,924 | Lilly Endowment, Inc, Endowment Arm | Company | 78,573 | US$662.81 | |
30 Jan 24 | SellUS$49,175,200 | Lilly Endowment, Inc, Endowment Arm | Company | 76,215 | US$646.27 | |
29 Jan 24 | SellUS$34,854,422 | Lilly Endowment, Inc, Endowment Arm | Company | 54,032 | US$645.07 | |
16 Jan 24 | SellUS$761,806 | Lilly Endowment, Inc, Endowment Arm | Company | 1,180 | US$646.17 | |
11 Jan 24 | SellUS$7,827,686 | Lilly Endowment, Inc, Endowment Arm | Company | 12,344 | US$639.13 | |
10 Jan 24 | SellUS$103,246,373 | Lilly Endowment, Inc, Endowment Arm | Company | 163,730 | US$636.29 | |
09 Jan 24 | SellUS$21,821,413 | Lilly Endowment, Inc, Endowment Arm | Company | 34,538 | US$633.41 | |
04 Jan 24 | SellUS$9,068,445 | Lilly Endowment, Inc, Endowment Arm | Company | 14,388 | US$631.07 | |
11 Oct 23 | SellUS$130,169,879 | Lilly Endowment, Inc, Endowment Arm | Company | 215,000 | US$607.74 | |
07 Sep 23 | SellUS$119,995,275 | Lilly Endowment, Inc, Endowment Arm | Company | 210,000 | US$575.37 | |
31 Aug 23 | SellUS$25,821,607 | Lilly Endowment, Inc, Endowment Arm | Company | 46,541 | US$557.19 | |
30 Aug 23 | SellUS$3,432,417 | Lilly Endowment, Inc, Endowment Arm | Company | 6,181 | US$557.36 | |
29 Aug 23 | SellUS$15,928,697 | Lilly Endowment, Inc, Endowment Arm | Company | 28,747 | US$555.85 | |
28 Aug 23 | SellUS$20,868,163 | Lilly Endowment, Inc, Endowment Arm | Company | 37,660 | US$555.54 | |
25 Aug 23 | SellUS$35,243,238 | Lilly Endowment, Inc, Endowment Arm | Company | 63,572 | US$556.06 | |
24 Aug 23 | SellUS$11,645,029 | Lilly Endowment, Inc, Endowment Arm | Company | 20,992 | US$556.34 | |
23 Aug 23 | SellUS$726,284 | Lilly Endowment, Inc, Endowment Arm | Company | 1,307 | US$555.69 | |
15 Aug 23 | SellUS$27,306,747 | Lilly Endowment, Inc, Endowment Arm | Company | 50,222 | US$546.73 | |
14 Aug 23 | SellUS$88,829,243 | Lilly Endowment, Inc, Endowment Arm | Company | 164,778 | US$542.10 | |
11 Aug 23 | SellUS$43,886,430 | Lilly Endowment, Inc, Endowment Arm | Company | 83,039 | US$531.34 | |
10 Aug 23 | SellUS$1,584,405 | Lilly Endowment, Inc, Endowment Arm | Company | 3,000 | US$528.14 | |
09 Aug 23 | SellUS$65,554,314 | Lilly Endowment, Inc, Endowment Arm | Company | 123,961 | US$532.18 | |
08 Aug 23 | SellUS$107,056,405 | Lilly Endowment, Inc, Endowment Arm | Company | 204,409 | US$536.95 | |
21 Jul 23 | SellUS$275,773 | Lilly Endowment, Inc, Endowment Arm | Company | 591 | US$466.62 | |
30 Jun 23 | SellUS$76,744,390 | Lilly Endowment, Inc, Endowment Arm | Company | 164,125 | US$469.22 | |
29 Jun 23 | SellUS$25,990,305 | Lilly Endowment, Inc, Endowment Arm | Company | 55,875 | US$466.24 | |
22 Jun 23 | SellUS$49,153,574 | Lilly Endowment, Inc, Endowment Arm | Company | 107,022 | US$462.11 | |
21 Jun 23 | SellUS$14,284,313 | Lilly Endowment, Inc, Endowment Arm | Company | 31,454 | US$455.00 | |
20 Jun 23 | SellUS$15,509,556 | Lilly Endowment, Inc, Endowment Arm | Company | 34,156 | US$454.08 | |
16 Jun 23 | SellUS$11,394,292 | Lilly Endowment, Inc, Endowment Arm | Company | 25,015 | US$456.50 | |
15 Jun 23 | SellUS$12,422,248 | Lilly Endowment, Inc, Endowment Arm | Company | 27,353 | US$455.04 | |
19 May 23 | SellUS$86,024,241 | Lilly Endowment, Inc, Endowment Arm | Company | 194,354 | US$447.29 | |
12 May 23 | SellUS$9,141,436 | Lilly Endowment, Inc, Endowment Arm | Company | 20,646 | US$444.40 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 114,138 | 0.0127% |
State or Government | 870,185 | 0.0966% |
Individual Insiders | 1,323,823 | 0.147% |
General Public | 103,154,399 | 11.5% |
Institutions | 794,942,841 | 88.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
98,898,810 | US$76.9b | -0.87% | 100.0% | |||
71,611,201 | US$55.7b | 1.47% | 0.88% | |||
64,366,433 | US$50.1b | -1.99% | 0.84% | |||
51,452,948 | US$40.0b | -0.13% | 30.48% | |||
41,658,368 | US$32.4b | 2.3% | 1.57% | |||
33,787,327 | US$26.3b | 1.14% | 1.03% | |||
30,562,908 | US$23.8b | 1.9% | 1.49% | |||
22,938,644 | US$17.8b | -2.56% | 1.57% | |||
22,200,534 | US$17.3b | -3.74% | 11.91% | |||
16,355,112 | US$12.7b | -4.68% | 10.7% | |||
15,955,639 | US$12.4b | 1.54% | 0.99% | |||
13,326,625 | US$10.4b | 22.7% | 1.24% | |||
11,779,826 | US$9.2b | -8.36% | 1.34% | |||
10,280,810 | US$8.0b | 10.1% | 0.66% | |||
9,132,343 | US$7.1b | -10.1% | 1.08% | |||
7,466,502 | US$5.8b | -1.73% | 3.51% | |||
7,133,399 | US$5.5b | 20.4% | 1.07% | |||
7,042,309 | US$5.5b | 6.77% | 0.73% | |||
6,778,374 | US$5.3b | 6.02% | 0.67% | |||
6,663,987 | US$5.2b | -8.55% | 0.94% | |||
5,753,925 | US$4.5b | 0% | 1.15% | |||
5,209,575 | US$4.1b | 1.52% | 1.02% | |||
5,062,301 | US$3.9b | 2.98% | 1.19% | |||
4,654,727 | US$3.6b | 2.53% | 0.72% | |||
4,560,553 | US$3.5b | -0.02% | 0.6% |